source
- After being ditched by Candid, Rallybio finds Avenzo to take its Nasdaq listingAvenzo Therapeutics, one of the first biotechs to get major Western VC backing to in-license Chinese assets, will go public in a reverse merger with Rallybio. The Monday morning deal comes ...Endpoints · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and moreDetailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall survival, from 13.2 months to 6.7 monthsSTAT · 1mo ago↗ source
- Opinion: What should hospitals do when patients demand unvaccinated donor blood?“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast” about requests for unvaccinated donor blood.